Literature DB >> 18470478

Role of the A chain in thrombin function.

M E Papaconstantinou1, A Bah, E Di Cera.   

Abstract

The A chain of thrombin is covalently linked to the catalytic B chain but is separate from any known epitope for substrate recognition. In this study we present the results of the Ala replacement of 12 charged residues controlling the stability of the A chain and its interaction with the B chain. Residues Arg4 and Glu8 play a significant role in substrate recognition, even though they are located > 20 A away from residues of the catalytic triad, the primary specificity pocket and the Na+ site. The R4A mutation causes significant perturbation of Na+ binding, fibrinogen clotting and PAR1 cleavage, but modest reduction of protein C activation in the presence of thrombomodulin. These findings challenge our current paradigm of thrombin structure-function relations focused exclusively on the properties of the catalytic B chain, and explain why certain naturally occurring mutations of the A chain cause serious bleeding.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18470478      PMCID: PMC2667268          DOI: 10.1007/s00018-008-8179-y

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  25 in total

1.  The prothrombin Denver patient has two different prothrombin point mutations resulting in Glu-300-->Lys and Glu-309-->Lys substitutions.

Authors:  J B Lefkowitz; T Haver; S Clarke; L Jacobson; A Weller; R Nuss; M Manco-Johnson; W E Hathaway
Journal:  Br J Haematol       Date:  2000-01       Impact factor: 6.998

2.  Mechanism of action of thrombin on fibrinogen. On the role of the A chain of bovine thrombin in specificity and in differentiating between thrombin and trypsin.

Authors:  T C Hageman; G F Endres; H A Scheraga
Journal:  Arch Biochem Biophys       Date:  1975-11       Impact factor: 4.013

3.  Molecular mapping of thrombin-receptor interactions.

Authors:  Y M Ayala; A M Cantwell; T Rose; L A Bush; D Arosio; E Di Cera
Journal:  Proteins       Date:  2001-11-01

4.  Ser(214) is crucial for substrate binding to serine proteases.

Authors:  Maxwell M Krem; Swati Prasad; Enrico Di Cera
Journal:  J Biol Chem       Date:  2002-08-13       Impact factor: 5.157

5.  Molecular dissection of Na+ binding to thrombin.

Authors:  Agustin O Pineda; Christopher J Carrell; Leslie A Bush; Swati Prasad; Sonia Caccia; Zhi-Wei Chen; F Scott Mathews; Enrico Di Cera
Journal:  J Biol Chem       Date:  2004-05-19       Impact factor: 5.157

6.  Redesigning the monovalent cation specificity of an enzyme.

Authors:  Swati Prasad; Kelly J Wright; Dolly Banerjee Roy; Leslie A Bush; Angelene M Cantwell; Enrico Di Cera
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-11       Impact factor: 11.205

7.  Rational design of a potent anticoagulant thrombin.

Authors:  A M Cantwell; E Di Cera
Journal:  J Biol Chem       Date:  2000-12-22       Impact factor: 5.157

8.  A natural prothrombin mutant reveals an unexpected influence of A-chain structure on the activity of human alpha-thrombin.

Authors:  Raimondo De Cristofaro; Sepideh Akhavan; Cosimo Altomare; Andrea Carotti; Flora Peyvandi; Pier Mannuccio Mannucci
Journal:  J Biol Chem       Date:  2004-01-13       Impact factor: 5.157

9.  The refined 1.9-A X-ray crystal structure of D-Phe-Pro-Arg chloromethylketone-inhibited human alpha-thrombin: structure analysis, overall structure, electrostatic properties, detailed active-site geometry, and structure-function relationships.

Authors:  W Bode; D Turk; A Karshikov
Journal:  Protein Sci       Date:  1992-04       Impact factor: 6.725

10.  Thrombin is a Na(+)-activated enzyme.

Authors:  C M Wells; E Di Cera
Journal:  Biochemistry       Date:  1992-12-01       Impact factor: 3.162

View more
  15 in total

1.  Stabilization of the E* form turns thrombin into an anticoagulant.

Authors:  Alaji Bah; Christopher J Carrell; Zhiwei Chen; Prafull S Gandhi; Enrico Di Cera
Journal:  J Biol Chem       Date:  2009-05-27       Impact factor: 5.157

2.  Know your APC.

Authors:  Enrico Di Cera
Journal:  Blood       Date:  2009-06-04       Impact factor: 22.113

3.  Probing light chain mutation effects on thrombin via molecular dynamics simulations and machine learning.

Authors:  Jiajie Xiao; Ryan L Melvin; Freddie R Salsbury
Journal:  J Biomol Struct Dyn       Date:  2018-03-02

4.  Molecular dynamics simulations of aptamer-binding reveal generalized allostery in thrombin.

Authors:  Jiajie Xiao; Freddie R Salsbury
Journal:  J Biomol Struct Dyn       Date:  2016-11-29

5.  Crystal structures of prethrombin-2 reveal alternative conformations under identical solution conditions and the mechanism of zymogen activation.

Authors:  Nicola Pozzi; Zhiwei Chen; Fatima Zapata; Leslie A Pelc; Sergio Barranco-Medina; Enrico Di Cera
Journal:  Biochemistry       Date:  2011-11-08       Impact factor: 3.162

6.  Engineering thrombin for selective specificity toward protein C and PAR1.

Authors:  Francesca Marino; Leslie A Pelc; Austin Vogt; Prafull S Gandhi; Enrico Di Cera
Journal:  J Biol Chem       Date:  2010-04-19       Impact factor: 5.157

7.  Na+-binding modes involved in thrombin's allosteric response as revealed by molecular dynamics simulations, correlation networks and Markov modeling.

Authors:  Jiajie Xiao; Freddie R Salsbury
Journal:  Phys Chem Chem Phys       Date:  2019-02-20       Impact factor: 3.676

8.  Prothrombin structure: unanticipated features and opportunities.

Authors:  Nicola Pozzi; Enrico Di Cera
Journal:  Expert Rev Proteomics       Date:  2014-10-18       Impact factor: 3.940

9.  Na+ binding to meizothrombin desF1.

Authors:  M E Papaconstantinou; P S Gandhi; Z Chen; A Bah; E Di Cera
Journal:  Cell Mol Life Sci       Date:  2008-11       Impact factor: 9.261

10.  Hyperantithrombotic, noncytoprotective Glu149Ala-activated protein C mutant.

Authors:  Laurent O Mosnier; Antonella Zampolli; Edward J Kerschen; Reto A Schuepbach; Yajnavalka Banerjee; José A Fernández; Xia V Yang; Matthias Riewald; Hartmut Weiler; Zaverio M Ruggeri; John H Griffin
Journal:  Blood       Date:  2009-02-24       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.